These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 29939990)

  • 1. Whole blood transcriptome analysis in amyotrophic lateral sclerosis: A biomarker study.
    van Rheenen W; Diekstra FP; Harschnitz O; Westeneng HJ; van Eijk KR; Saris CGJ; Groen EJN; van Es MA; Blauw HM; van Vught PWJ; Veldink JH; van den Berg LH
    PLoS One; 2018; 13(6):e0198874. PubMed ID: 29939990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ALS blood expression profiling identifies new biomarkers, patient subgroups, and evidence for neutrophilia and hypoxia.
    Swindell WR; Kruse CPS; List EO; Berryman DE; Kopchick JJ
    J Transl Med; 2019 May; 17(1):170. PubMed ID: 31118040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a circulating miRNA signature in extracellular vesicles collected from amyotrophic lateral sclerosis patients.
    Saucier D; Wajnberg G; Roy J; Beauregard AP; Chacko S; Crapoulet N; Fournier S; Ghosh A; Lewis SM; Marrero A; O'Connell C; Ouellette RJ; Morin PJ
    Brain Res; 2019 Apr; 1708():100-108. PubMed ID: 30552897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Label-Free LC-MS/MS Proteomic Analysis of Cerebrospinal Fluid Identifies Protein/Pathway Alterations and Candidate Biomarkers for Amyotrophic Lateral Sclerosis.
    Collins MA; An J; Hood BL; Conrads TP; Bowser RP
    J Proteome Res; 2015 Nov; 14(11):4486-501. PubMed ID: 26401960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Diagnostic Gene-Expression Signature in Fibroblasts of Amyotrophic Lateral Sclerosis.
    Morello G; La Cognata V; Guarnaccia M; La Bella V; Conforti FL; Cavallaro S
    Cells; 2023 Jul; 12(14):. PubMed ID: 37508548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrative gene-tissue microarray-based approach for identification of human disease biomarkers: application to amyotrophic lateral sclerosis.
    Kudo LC; Parfenova L; Vi N; Lau K; Pomakian J; Valdmanis P; Rouleau GA; Vinters HV; Wiedau-Pazos M; Karsten SL
    Hum Mol Genet; 2010 Aug; 19(16):3233-53. PubMed ID: 20530642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An Integrative Transcriptome-Wide Analysis of Amyotrophic Lateral Sclerosis for the Identification of Potential Genetic Markers and Drug Candidates.
    Park S; Kim D; Song J; Joo JWJ
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33809961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RNA editing regulates glutamatergic synapses in the frontal cortex of a molecular subtype of Amyotrophic Lateral Sclerosis.
    Karagianni K; Dafou D; Xanthopoulos K; Sklaviadis T; Kanata E
    Mol Med; 2024 Jul; 30(1):101. PubMed ID: 38997636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased expression of Myosin binding protein H in the skeletal muscle of amyotrophic lateral sclerosis patients.
    Conti A; Riva N; Pesca M; Iannaccone S; Cannistraci CV; Corbo M; Previtali SC; Quattrini A; Alessio M
    Biochim Biophys Acta; 2014 Jan; 1842(1):99-106. PubMed ID: 24184715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma metabolomic biomarker panel to distinguish patients with amyotrophic lateral sclerosis from disease mimics.
    Lawton KA; Brown MV; Alexander D; Li Z; Wulff JE; Lawson R; Jaffa M; Milburn MV; Ryals JA; Bowser R; Cudkowicz ME; Berry JD;
    Amyotroph Lateral Scler Frontotemporal Degener; 2014 Sep; 15(5-6):362-70. PubMed ID: 24984169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genome-wide circulating microRNA expression profiling reveals potential biomarkers for amyotrophic lateral sclerosis.
    Matamala JM; Arias-Carrasco R; Sanchez C; Uhrig M; Bargsted L; Matus S; Maracaja-Coutinho V; Abarzua S; van Zundert B; Verdugo R; Manque P; Hetz C
    Neurobiol Aging; 2018 Apr; 64():123-138. PubMed ID: 29458840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic and prognostic significance of neurofilament light chain NF-L, but not progranulin and S100B, in the course of amyotrophic lateral sclerosis: Data from the German MND-net.
    Steinacker P; Huss A; Mayer B; Grehl T; Grosskreutz J; Borck G; Kuhle J; Lulé D; Meyer T; Oeckl P; Petri S; Weishaupt J; Ludolph AC; Otto M
    Amyotroph Lateral Scler Frontotemporal Degener; 2017 Feb; 18(1-2):112-119. PubMed ID: 27819158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New insights into the gene expression associated to amyotrophic lateral sclerosis.
    Recabarren-Leiva D; Alarcón M
    Life Sci; 2018 Jan; 193():110-123. PubMed ID: 29241710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Value of 18fluorodeoxyglucose-positron-emission tomography in amyotrophic lateral sclerosis: a prospective study.
    Van Laere K; Vanhee A; Verschueren J; De Coster L; Driesen A; Dupont P; Robberecht W; Van Damme P
    JAMA Neurol; 2014 May; 71(5):553-61. PubMed ID: 24615479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amyotrophic Lateral Sclerosis Survival Score (ALS-SS): A simple scoring system for early prediction of patient survival.
    Lunetta C; Lizio A; Melazzini MG; Maestri E; Sansone VA
    Amyotroph Lateral Scler Frontotemporal Degener; 2015; 17(1-2):93-100. PubMed ID: 26470943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biomarker-based predictive models for prognosis in amyotrophic lateral sclerosis.
    Su XW; Simmons Z; Mitchell RM; Kong L; Stephens HE; Connor JR
    JAMA Neurol; 2013 Dec; 70(12):1505-11. PubMed ID: 24145899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of blood RNA extraction methods used for gene expression profiling in amyotrophic lateral sclerosis.
    Bayatti N; Cooper-Knock J; Bury JJ; Wyles M; Heath PR; Kirby J; Shaw PJ
    PLoS One; 2014; 9(1):e87508. PubMed ID: 24475299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A CSF biomarker panel for identification of patients with amyotrophic lateral sclerosis.
    Mitchell RM; Freeman WM; Randazzo WT; Stephens HE; Beard JL; Simmons Z; Connor JR
    Neurology; 2009 Jan; 72(1):14-9. PubMed ID: 18987350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amyotrophic lateral sclerosis outcome measures and the role of albumin and creatinine: a population-based study.
    Chiò A; Calvo A; Bovio G; Canosa A; Bertuzzo D; Galmozzi F; Cugnasco P; Clerico M; De Mercanti S; Bersano E; Cammarosano S; Ilardi A; Manera U; Moglia C; Sideri R; Marinou K; Bottacchi E; Pisano F; Cantello R; Mazzini L; Mora G;
    JAMA Neurol; 2014 Sep; 71(9):1134-42. PubMed ID: 25048026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of plasma microRNAs as a biomarker of sporadic Amyotrophic Lateral Sclerosis.
    Takahashi I; Hama Y; Matsushima M; Hirotani M; Kano T; Hohzen H; Yabe I; Utsumi J; Sasaki H
    Mol Brain; 2015 Oct; 8(1):67. PubMed ID: 26497046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.